The U.S. Preventive Services Task Force’s new draft guideline now recommends that women aged 30–65 years get tested for high-risk genotypes of human papillomavirus (hrHPV) every 5 years or get a Pap screening every 3 years. That is a major change from the task force’s 2012 recommendation of cotesting: screening with the hrHPV test plus Pap screening every 5 years for women in that age group (Ann. Intern. Med. 2012;156:880–91; doi:10.7326/0003-4819-156-12-201206190-00424). A final guideline will be published after a period of public comment.

中文翻译：

---

宫颈癌的筛查指南建议抗人乳头瘤病毒-宫颈癌共同测试

现在，美国预防服务工作队的新指南草案建议30-65岁的女性每5年接受一次人类乳头瘤病毒（hrHPV）高风险基因型测试，或每3年进行一次子宫颈抹片检查。这是该小组的的cotesting 2012推荐一个重大变化：筛查与高危型HPV测试加上巴氏每5年筛查妇女在该年龄组（安内科杂志。 2012; 156：880-91; DOI：10.7326 / 0003-4819-156-12-201206190-00424）。经过一段时间的公众评论后，最终指南将发布。